S.AytonS.BarayeuU.BarteltA.et al (2024)
IV glutathione starting with a dose of 1,000 to 1,500 mg is our normal starting dose increasing the dose to 3,000 mg as tolerated
The clinical studies cited for GHK-Cu on human skin are small, primarily industry-sponsored, and not registered in clinical trial databases
Upregulation of Growth Factors: It increases the expression of receptors for growth factors (like VEGF ), accelerating the rate at which fibroblasts (collagen-producing cells) do their work
Bolte, L
Training and Education Board Certification American Board of Pediatrics, Pediatric Cardiology Fellowship Pediatric Cardiology, Vanderbilt University Medical Center (Tennessee), 2004-2007 Cardiovascular Pharmacology, Vanderbilt University Medical Center (Tennessee), 2006-2007 Advanced Cardiac Imaging, Vanderbilt University Medical Center (Tennessee), 2007-2008 Residency Pediatrics, Vanderbilt University Medical Center (Tennessee), 2001-2004 Education MD, University of South Carolina School of Medicine, 2001 MHA, University of North Carolina at Chapel Hill, 2016 Clinical Focus and Research I am passionate about research in the fields of pediatric cardiac imaging and congenital heart disease